Submission Details
| 510(k) Number | K160911 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 01, 2016 |
| Decision Date | June 28, 2016 |
| Days to Decision | 88 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K160911 is an FDA 510(k) clearance for the VIDAS B.R.A.H.M.S. PCT (PCT), a Device To Detect And Measure Procalcitonin (pct) In Human Clinical Specimens (Class II — Special Controls, product code PMT), submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on June 28, 2016, 88 days after receiving the submission on April 1, 2016. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3215.
| 510(k) Number | K160911 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 01, 2016 |
| Decision Date | June 28, 2016 |
| Days to Decision | 88 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | PMT — Device To Detect And Measure Procalcitonin (pct) In Human Clinical Specimens |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3215 |
| Definition | An Assay Used To Determine The Level Of Procalcitonin (pct) In Human Serum And Plasma As An Aid In Assessing The Mortality For Patients Diagnosed With Severe Sepsis Or Septic Shock. |